David Nierengarten
Stock Analyst at Wedbush
(4.81)
# 506
Out of 5,005 analysts
578
Total ratings
47.7%
Success rate
18.3%
Average return
Main Sectors:
Stocks Rated by David Nierengarten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRRK Scholar Rock Holding | Reiterated: Buy | $70 | $49.13 | +42.48% | 21 | Sep 25, 2026 | |
| XNCR Xencor | Reiterated: Buy | $30 | $25.60 | +17.19% | 18 | Sep 25, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $165 | $84.19 | +95.99% | 9 | Sep 24, 2026 | |
| ABVX ABIVAX Société Anonyme | Reiterated: Hold | $140 → $118 | $96.85 | +21.84% | 7 | Sep 22, 2026 | |
| COGT Cogent Biosciences | Reiterated: Buy | $55 | $31.86 | +72.63% | 23 | Sep 16, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $11 | $2.50 | +340.00% | 16 | Sep 15, 2026 | |
| NUVB Nuvation Bio | Reiterated: Buy | $11 | $5.60 | +96.43% | 29 | Sep 15, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $65 | $24.23 | +168.26% | 20 | Sep 9, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Hold | $17 → $13 | $11.42 | +13.84% | 16 | Sep 9, 2026 | |
| SYRE Spyre Therapeutics | Reiterated: Buy | $123 | $85.79 | +43.37% | 13 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,150 | $972.25 | +18.28% | 61 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $1 | $0.34 | +194.12% | 7 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $19.35 | +80.88% | 1 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $27.55 | +63.34% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $64 | $33.12 | +93.24% | 4 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $6.43 | +71.07% | 4 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $20.75 | +92.77% | 6 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 | $64.92 | +35.55% | 22 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $21.47 | +39.73% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 → $99 | $76.10 | +30.09% | 23 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $20 | $15.83 | +26.34% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $60 | $16.03 | +274.30% | 16 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $3.81 | +556.17% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $50.80 | +47.64% | 33 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $39.79 | -19.58% | 2 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $7.05 | +226.24% | 5 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $13.27 | +50.72% | 22 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 69.00 | kr 33.50 | +105.97% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $75 → $35 | $14.41 | +142.89% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $18.31 | n/a | 11 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $30 | $18.80 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $2.38 | n/a | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $21.68 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $4.64 | n/a | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $2.88 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $4 | $1.62 | n/a | 23 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $2 | $23.51 | n/a | 5 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $48 → $16 | $87.83 | n/a | 8 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $17 | $10.95 | n/a | 6 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $32 | $4.06 | n/a | 11 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $10 | $0.0004 | n/a | 3 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $36 | $2.70 | n/a | 7 | Jun 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $681.94 | n/a | 1 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $13 | $8.74 | n/a | 2 | Apr 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $10.61 | n/a | 1 | Dec 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.15 | n/a | 1 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $3.41 | n/a | 6 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $13 | $4.12 | n/a | 6 | Oct 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $0.0001 | n/a | 7 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.36 | n/a | 7 | Aug 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $31.49 | n/a | 3 | May 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $9 | $0.75 | n/a | 4 | Nov 17, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $117.67 | n/a | 3 | Mar 31, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $23.49 | n/a | 1 | Mar 22, 2013 |
Scholar Rock Holding
Sep 25, 2026
Reiterated: Buy
Price Target: $70
Current: $49.13
Upside: +42.48%
Xencor
Sep 25, 2026
Reiterated: Buy
Price Target: $30
Current: $25.60
Upside: +17.19%
Oruka Therapeutics
Sep 24, 2026
Reiterated: Buy
Price Target: $165
Current: $84.19
Upside: +95.99%
ABIVAX Société Anonyme
Sep 22, 2026
Reiterated: Hold
Price Target: $140 → $118
Current: $96.85
Upside: +21.84%
Cogent Biosciences
Sep 16, 2026
Reiterated: Buy
Price Target: $55
Current: $31.86
Upside: +72.63%
Perspective Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $11
Current: $2.50
Upside: +340.00%
Nuvation Bio
Sep 15, 2026
Reiterated: Buy
Price Target: $11
Current: $5.60
Upside: +96.43%
Beam Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $65
Current: $24.23
Upside: +168.26%
Intellia Therapeutics
Sep 9, 2026
Reiterated: Hold
Price Target: $17 → $13
Current: $11.42
Upside: +13.84%
Spyre Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $123
Current: $85.79
Upside: +43.37%
Sep 3, 2026
Reiterated: Buy
Price Target: $1,150
Current: $972.25
Upside: +18.28%
Sep 3, 2026
Downgraded: Hold
Price Target: $5 → $1
Current: $0.34
Upside: +194.12%
Aug 19, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $19.35
Upside: +80.88%
Aug 14, 2026
Reiterated: Buy
Price Target: $45
Current: $27.55
Upside: +63.34%
Aug 12, 2026
Reiterated: Buy
Price Target: $55 → $64
Current: $33.12
Upside: +93.24%
Aug 12, 2026
Reiterated: Buy
Price Target: $11
Current: $6.43
Upside: +71.07%
Aug 11, 2026
Reiterated: Buy
Price Target: $40
Current: $20.75
Upside: +92.77%
Aug 11, 2026
Reiterated: Buy
Price Target: $88
Current: $64.92
Upside: +35.55%
Aug 5, 2026
Reiterated: Buy
Price Target: $30
Current: $21.47
Upside: +39.73%
Jul 28, 2026
Reiterated: Buy
Price Target: $72 → $99
Current: $76.10
Upside: +30.09%
Jul 24, 2026
Reiterated: Hold
Price Target: $18 → $20
Current: $15.83
Upside: +26.34%
May 18, 2026
Upgraded: Buy
Price Target: $22 → $60
Current: $16.03
Upside: +274.30%
May 13, 2026
Reiterated: Buy
Price Target: $25
Current: $3.81
Upside: +556.17%
Mar 31, 2026
Reiterated: Buy
Price Target: $75
Current: $50.80
Upside: +47.64%
Mar 17, 2026
Reiterated: Buy
Price Target: $32
Current: $39.79
Upside: -19.58%
Mar 11, 2026
Reiterated: Buy
Price Target: $23
Current: $7.05
Upside: +226.24%
Feb 24, 2026
Reiterated: Buy
Price Target: $20
Current: $13.27
Upside: +50.72%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: kr 69.00
Current: kr 33.50
Upside: +105.97%
Oct 14, 2025
Reiterated: Hold
Price Target: $75 → $35
Current: $14.41
Upside: +142.89%
Jun 26, 2025
Reiterated: Hold
Price Target: $8
Current: $18.31
Upside: n/a
May 23, 2025
Reiterated: Buy
Price Target: $31 → $30
Current: $18.80
Upside: n/a
May 14, 2025
Reiterated: Hold
Price Target: $5
Current: $2.38
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $33
Current: $21.68
Upside: n/a
Aug 9, 2024
Reiterated: Hold
Price Target: $2
Current: $4.64
Upside: n/a
Apr 2, 2024
Initiated Coverage: Buy
Price Target: $12
Current: $2.88
Upside: n/a
Jul 26, 2023
Reiterated: Hold
Price Target: $9 → $4
Current: $1.62
Upside: n/a
Jul 12, 2023
Downgraded: Hold
Price Target: $4 → $2
Current: $23.51
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: $48 → $16
Current: $87.83
Upside: n/a
Jan 25, 2023
Reiterated: Buy
Price Target: $19 → $17
Current: $10.95
Upside: n/a
Jun 16, 2021
Reiterated: Buy
Price Target: $34 → $32
Current: $4.06
Upside: n/a
Aug 7, 2020
Reiterated: Hold
Price Target: $9 → $10
Current: $0.0004
Upside: n/a
Jun 18, 2019
Reiterated: Buy
Price Target: $19 → $36
Current: $2.70
Upside: n/a
Aug 16, 2018
Reiterated: Buy
Price Target: $95
Current: $681.94
Upside: n/a
Apr 23, 2018
Reiterated: Hold
Price Target: $55 → $13
Current: $8.74
Upside: n/a
Dec 21, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $10.61
Upside: n/a
Nov 28, 2017
Initiated Coverage: Buy
Price Target: $20
Current: $1.15
Upside: n/a
Oct 12, 2017
Reiterated: Buy
Price Target: $24 → $16
Current: $3.41
Upside: n/a
Oct 24, 2016
Reiterated: Hold
Price Target: $10 → $13
Current: $4.12
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $1.5 → $1
Current: $0.0001
Upside: n/a
Aug 3, 2016
Reiterated: Hold
Price Target: $2
Current: $1.36
Upside: n/a
May 9, 2016
Reiterated: Hold
Price Target: $4 → $3
Current: $31.49
Upside: n/a
Nov 17, 2015
Reiterated: Buy
Price Target: $16 → $9
Current: $0.75
Upside: n/a
Mar 31, 2014
Reiterated: Sell
Price Target: n/a
Current: $117.67
Upside: n/a
Mar 22, 2013
Reiterated: Hold
Price Target: n/a
Current: $23.49
Upside: n/a